Israel-based biomedical company Nurami Medical has raised US$30 million in its latest funding round.

The funds will help expand its workforce and scale operations, including the construction of a commercial manufacturing facility, research and development lab, and clean rooms for producing its first FDA-approved product.

Nurami develops products for neurological surgeries, specifically addressing cerebrospinal fluid leakage.

Founded in 2014 by Nora Nseir and Dr. Amir Bahar, the company recently received regulatory approval for a nanofiber-based surgical patch designed to support post-surgical recovery by naturally degrading and integrating into the body.